Drug Search Results
More Filters [+]

BALTACCIDBPE-100

Alternative Names: baltaccidbpe-100, baltaccidbpe100, baltaccidbpe 100
Latest Update: 2022-06-23
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Michael A Belfort
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BALTACCIDBPE-100

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hernias, Diaphragmatic, Congenital

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

TOTAL

P2

Completed

Hernias, Diaphragmatic, Congenital

2019-10-01

Recent News Events

Date

Type

Title